<?xml version="1.0" encoding="UTF-8"?>
<p>The inhibitory effects of polyanionic substances on the replication of HSV and other viruses were reported almost five decades ago. Shortly after the identification of HIV as the causative agent of AIDS in 1984, heparin and other sulfated polysaccharides were found to be potent and selective inhibitors of HIV-1 replication in cell culture. Since 1988, the activity spectrum of the sulfated polysaccharides has been shown to extend to various enveloped viruses, including HSV 
 <italic>in vitro</italic> (Karmakar et al. 
 <xref ref-type="bibr" rid="CR81_3">2010</xref>; Herold et al. 
 <xref ref-type="bibr" rid="CR65_3">1995</xref>), human cytomegalovirus (HCMV) (Baba et al. 
 <xref ref-type="bibr" rid="CR13_3">1988</xref>), respiratory syncytial virus, influenza A and B virus (Damonte et al. 
 <xref ref-type="bibr" rid="CR38_3">1994</xref>), DENV-2 and DENV-3 in the human hepatoma HepG2 (Talarico et al. 
 <xref ref-type="bibr" rid="CR172_3">2005</xref>).
</p>
